Express News | Collegium Pharmaceutical Announces FDA Grant Of Pediatric Exclusivity For Nucynta Franchise; Extends U.S. Exclusivity To January 2027 For Nucynta And December 2025 For Nucynta ER
Express News | Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is usu
Street Calls of the Week: Upgrades for Best Buy and Lululemon
Collegium Pharmaceutical Price Target Raised to $44.00/Share From $41.00 by Jefferies
Collegium Pharmaceutical Price Target Raised to $44.00/Share From $41.00 by Jefferies
Collegium Pharmaceutical Raised to Buy From Hold by Jefferies
Collegium Pharmaceutical Raised to Buy From Hold by Jefferies
Collegium Pharmaceutical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/07/2024 34.89% Jefferies $41 → $44 Upgrades Hold → Buy 05/10/2024 — Needham Downgrades Buy → Hold 05/1
Jefferies Upgrades Collegium to Buy, Cites Upside Related to LOEs
Jefferies Upgrades Collegium Pharmaceutical(COLL.US) to Buy Rating, Raises Target Price to $44
Jefferies analyst Glen Santangelo upgrades $Collegium Pharmaceutical(COLL.US)$ to a buy rating, and adjusts the target price from $37 to $44.According to TipRanks data, the analyst has a success rate
Express News | Collegium Pharmaceutical Inc : Jefferies Raises Target Price to $44 From $41
Express News | Collegium Pharmaceutical Inc : Jefferies Raises to Buy From Hold
Form 144 | Collegium Pharmaceutical(COLL.US) Insider Proposes to Sell 4.16 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 5, $Collegium Pharmaceutical(COLL.US)$ Insider Ciaffoni Joseph intends to sell 131.2K shares of its common stock on Jun 5, with a total market value of approximately $4.16
Collegium Pharmaceutical(COLL.US) Officer Sells US$814.18K in Common Stock
$Collegium Pharmaceutical(COLL.US)$ Officer Kuhlmann Shirley R. sold 25,000 shares of common stock on Jun 3, 2024 at an average price of $32.5672 for a total value of $814.18K.Source: Announcement Wha
Collegium Pharmaceutical Insider Sold Shares Worth $814,180, According to a Recent SEC Filing
Shirley R. Kuhlmann, Executive Vice President and General Counsel, on June 03, 2024, sold 25,000 shares in Collegium Pharmaceutical (COLL) for $814,180. Following the Form 4 filing with the SEC, Kuhlm
Form 144 | Collegium Pharmaceutical(COLL.US) Insider Proposes to Sell 2.66 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 4, $Collegium Pharmaceutical(COLL.US)$ Insider Ciaffoni Joseph intends to sell 84,313 shares of its common stock on Jun 4, with a total market value of approximately $2.66
Form 144 | Collegium Pharmaceutical(COLL.US) Insider Proposes to Sell 1.71 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 3, $Collegium Pharmaceutical(COLL.US)$ Insider Ciaffoni Joseph intends to sell 52,572 shares of its common stock on Jun 3, with a total market value of approximately $1.71
Form 144 | Collegium Pharmaceutical(COLL.US) Officer Proposes to Sell 820.75K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 3, $Collegium Pharmaceutical(COLL.US)$ Officer Kuhlmann Shirley R. intends to sell 25,000 shares of its common stock on Jun 3, with a total market value of approximately $8
Form 144 | Collegium Pharmaceutical(COLL.US) Insider Proposes to Sell 1.79 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 30, $Collegium Pharmaceutical(COLL.US)$ Insider Ciaffoni Joseph intends to sell 54,147 shares of its common stock on May 30, with a total market value of approximately $1.7
Collegium Pharmaceutical(COLL.US) Officer Sells US$674.37K in Common Stock
$Collegium Pharmaceutical(COLL.US)$ Officer Tupper Colleen sold 19,710 shares of common stock on May 28, 2024 at an average price of $34.2145 for a total value of $674.37K.Source: Announcement What is
Form 144(Amend) | Collegium Pharmaceutical(COLL.US) Insider Proposes to Sell 1.84 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 29, $Collegium Pharmaceutical(COLL.US)$ Insider Ciaffoni Joseph intends to sell 54,146 shares of its common stock on May 29, with a total market value of approximately $1.8
No Data